Pulmonx, a Palo Alto, Calif. developer of medical devices for interventional pulmonology, has secured commitments of about $18.5 million for a $20.5 million second round, according to a regulatory filing cited by PE Week. MedVenture Associates was joined by existing investors, including Montreux Equity Partners.